When did Haemonetics report Q3 2025 earnings?

Haemonetics (HAE) reported Q3 2025 earnings on February 6, 2025 before market open.

What were Haemonetics's Q3 2025 revenue and EPS?

Haemonetics reported revenue of $348.5M and eps of $1.19 for Q3 2025.

Did Haemonetics beat estimates in Q3 2025?

Revenue missed the consensus estimate of $354.5M by $5.9M. EPS beat the consensus estimate of $1.18 by $0.01.

Where can I find Haemonetics's Q3 2025 SEC filings?

You can read the 10-Q periodic report (0000313143-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.

Haemonetics HAE Q3 2025 earnings

Reported February 6, 2025 · Before market open

Revenue$348.5MMiss by $5.9M

EPS$1.19Beat by $0.01

Revenue estimate$354.5M

EPS estimate$1.18

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$327.9M

EPS estimate$1.07

Financials

Q3 2025

Income statement

See full

Revenue$348.5M+3.7%

Gross profit$193.5M+8.8%

Operating income$59.0M+28.4%

Net income$37.5M+20.0%

EPS (diluted)$0.74+21.3%

Balance sheet

See full

Cash & equivalents$320.8M+65.4%

Total debt$1.2B+40.7%

Total equity$906.9M-3.9%

Total assets$2.5B+15.0%

Cash flow

See full

Operating cash flow$43.8M—

CapEx$8.5M-41.6%

Free cash flow$35.2M—

Valuation & ratios

Valuation

as of 12/28/24

See full

Market cap$3.92B-9.6%

Enterprise value$4.83B-3.8%

P/E30.2×-4.1×

P/S2.9×-0.6×

Profitability

See full

Gross margin53.3%+0.4pp

Operating margin13.1%-0.3pp

Net margin9.5%-0.5pp

FCF margin7.2%—

Returns & leverage

See full

Return on equity14.1%-0.7pp

Debt / equity1.4×+0.4×

Current ratio4×+1.0×

Segments

By geography

See full

Europe$44.2M+10.3%

Asia$25.6M-17.3%

Rest of Asia$25.6M-4.8%

Other$4.9M+48.9%

Other Countryor Region$4.9M+86.5%

By segment

See full

Hospital$144.0M—

Plasma$134.2M—

Blood Center$70.3M—

By product

See full

Hospital$287.9M+23.9%

Blood Center$140.7M-2.8%

Plasma$134.2M-9.1%

Versus estimates

Revenue

Q4 2026$346.4MBeat by $9.5M Q3 2026$339.0MBeat by $7.1M Q2 2026$327.3MMiss by $2.5M Q1 2026$321.4MBeat by $1.4M Q4 2025$330.6MBeat by $18.1M

Q3 2025$348.5MMiss by $5.9M

Diluted EPS

Q4 2026$1.29Beat by $0.01 Q3 2026$1.31Beat by $0.04 Q2 2026$1.27Beat by $0.15 Q1 2026$1.10Beat by $0.09 Q4 2025$1.24Beat by $0.02

Q3 2025$1.19Beat by $0.01

Ask the moment Haemonetics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Haemonetics report Q3 2025 earnings?: Haemonetics (HAE) reported Q3 2025 earnings on February 6, 2025 before market open.
What were Haemonetics's Q3 2025 revenue and EPS?: Haemonetics reported revenue of $348.5M and eps of $1.19 for Q3 2025.
Did Haemonetics beat estimates in Q3 2025?: Revenue missed the consensus estimate of $354.5M by $5.9M. EPS beat the consensus estimate of $1.18 by $0.01.
Where can I find Haemonetics's Q3 2025 SEC filings?: You can read the 10-Q periodic report (0000313143-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.